| 英文名稱 | Secoxyloganin |
|---|---|
| 中文名稱 | 斷氧化馬錢子苷/幼枝含斷氧化馬錢子甙/2-((2S,3R,4S)-5-(甲氧基羰基)-2-(((2S,3R,4S,5S,6R)-3,4,5-三羥基-6-(羥甲基)四氫-2H-吡喃-2-基)氧基)-3-乙烯基-3,4-二氫-2H-吡喃-4-基)乙酸/幼枝含斷氧化馬錢子苷/斷氧化馬錢苷 |
| CAS號 | 58822-47-2 |
| 分子式 | C17H24O11 |
| 分子量 | 404.37 |
| 外觀 | |
| 沸點(diǎn) | 649.5±55.0 °C | Condition: Press: 760 Torr |
| 酸度系數(shù)pKa | 4.40±0.10 | Condition: Most Acidic Temp: 25 °C |
| A network analysis of the Chinese medicine Lianhua-Qingwen formula to identify its main effective components | ||
| 來源：SCI：Molecular BioSystems | 作者：Chun-Hua Wang | 備注：影響因子：3.21 |
| 引用描述 | ||
26 of 61 candidate components are commercially available in Sigma Aldrich (St. Louis, MO, USA), SUPELCO (Bellefonte, USA), China National Institutes for Food and Drug Control (Beijing, China), Zhongxin Innova Laboratories (Tianjin, China), Sichuan Weikeqi Biological Technology Co., Ltd. (Chengdu, China), Sima-Lab (Tianjin, China), and Yifang Technology (Tianjin, China). The antiviral potentials of these 26 components were tested by the cytopathic effect (CPE) method in vitro against RSV A2 virus to evaluate the identification accuracy of main effective components.17,18 Briefly, HEp-2 cells were seeded in a 96-well plate | ||
